Here is the latest shareholding Pattern of INDRAPRASTHA MEDICAL. For more details, see the INDRAPRASTHA MEDICAL financial fact sheet and INDRAPRASTHA MEDICAL share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 49.39 | 49.39 | 49.39 | 49.39 | 49.39 | 49.39 | 49.39 | 49.39 | |
Foreign Promoters | % | 1.61 | 1.61 | 1.61 | 1.61 | 1.61 | 1.61 | 1.61 | 1.61 | |
Total Promoters | % | 51.00 | 51.00 | 51.00 | 51.00 | 51.00 | 51.00 | 51.00 | 51.00 | |
Mutual Funds | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Financial institution/Banks/Insurance | % | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 6.71 | 6.36 | 4.91 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 0.09 | 0.15 | 0.77 | 0.27 | 0.37 | 0.81 | 0.95 | 1.08 | |
Other | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.01 | 0.00 | |
Total Institution | % | 0.11 | 0.17 | 0.77 | 0.27 | 0.37 | 7.51 | 7.32 | 5.99 | |
Bodies Corporate | % | 12.56 | 12.68 | 13.06 | 13.92 | 13.99 | 7.25 | 7.24 | 7.81 | |
Individuals | % | 31.40 | 31.25 | 30.11 | 29.66 | 29.31 | 28.94 | 29.32 | 29.58 | |
NRIs/OCBs | % | 2.58 | 2.51 | 2.46 | 2.37 | 2.49 | 2.47 | 2.55 | 2.42 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 2.35 | 2.39 | 2.59 | 2.77 | 2.83 | 2.83 | 2.57 | 3.20 | |
Total Non-Institution | % | 48.89 | 48.83 | 48.22 | 48.72 | 48.62 | 41.49 | 41.68 | 43.01 | |
Total Public | % | 49.00 | 49.00 | 49.00 | 49.00 | 49.00 | 49.00 | 49.00 | 49.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Subscriber Feature |
More Hospital & Healthcare Services Company Shareholding Pattern: ZYDUS LIFESCIENCES CIPLA DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB
Asian shares rose cautiously on Friday as markets sobered up to the idea that U.S. rate cuts were most likely some time away.